Northern Research was founded in 2019 with the objektive to develop the next generation of advanced heart assist devices.
The company has a team of leading engineers and scientists in pump and sensor technologies including more than 100 years of accumulated experience in development and managing heart assist devices.
Northern Research has head office in Oslo, Norway.
Northern Research has a daughter company in Sydney, Australia where pilot production, managing and testing of devices are performed in advanced facilities.
Northern Research partners with top ranked international institutions in Europe, Australia, Middle East, and USA.
PulseVad is the first generation Smart pump coming to the market.
PulseVad provides adaptive and pulsatile flow, syncronized to the heart, using new sensor technology. The pump has adaptive flow according to patient physiological need.
The pulsed flow and pump design reduce the risk of thrombus formation and risk of celebral emboli.
PulseVad will be implanted minimally invasive and off pump, with a special designed system for access and placement.
Syncronized flow – Minimal Invasive implant – Adaptive to patients needs – Route LA to DA – Thrombus minimalization
Total market potential for long-term assist devices is estimated to be
approx 160.000 pcs, with a 50/50 split between patients with preserved and reduced EF.
Currently no medical treatment is offered to patients with preserved EF, and where PulseVad will offer a break through technology when introduced in the market.
PulseVad will also offer treatment options for the traditional VAD patient with reduced EF.